The SNAP trial

The Staphylococcus aureus bacteremia Network Adaptive Platform Trial is an innovative trial to evaluate a range of interventions with the aim of improving outcomes for patients with Staphylococcus aureus bacteremia (AKA bloodstream infection).


The study includes sites from throughout Australia, New Zealand, Singapore, Canada and Israel and has the potential to include sites from elsewhere in the world